The role of CDK11B is closely related to increased glycerophospholipid metabolism, while AMDHD2 has been reported through previous study to mediate immune system dysfunction and increase the risk of cancer, whether it could lead to neurological immune dysfunction during or post COVID is therefore worth further study [29,65–67]. This evidence concerns the gene AMDHD2 and immune system disorder.